CORRECTION article

Front. Immunol., 12 August 2021

Sec. Alloimmunity and Transplantation

Volume 12 - 2021 | https://doi.org/10.3389/fimmu.2021.739229

Corrigendum: The Aquaporin 5 −1364A/C Promoter Polymorphism Is Associated With Cytomegalovirus Infection Risk in Kidney Transplant Recipients

  • 1. Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany

  • 2. Klinik für Chirurgie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany

Sandra Frisenda was not included as an author in the published article. The corrected Author Contributions Statement appears below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Statements

Author contributions

TR, HN, PS, RV, MA, and LB: conceived and designed the research. SF, TR, HN, KR, BK, and LB: performed the experiments. KR and BK: contributed the reagents. TR, SF, PS, RV, MA, and LB: collected and provided the clinical data. TR, HN, BK, PS, MA, and LB: interpreted the data. TR, HN, MA, and LB: performed the statistical analysis. TR, HN, PS, and LB: wrote the initial draft. All authors critically revised and approved the manuscript and are accountable for the accuracy and integrity of the work.

Summary

Keywords

AQP5, single nucleotide polymorphism (SNP), cytomegalovirus, immunosuppression, infection risk, kidney transplantation

Citation

Rahmel T, Nowak H, Frisenda S, Rump K, Koos B, Schenker P, Viebahn R, Adamzik M and Bergmann L (2021) Corrigendum: The Aquaporin 5 −1364A/C Promoter Polymorphism Is Associated With Cytomegalovirus Infection Risk in Kidney Transplant Recipients. Front. Immunol. 12:739229. doi: 10.3389/fimmu.2021.739229

Received

10 July 2021

Accepted

27 July 2021

Published

12 August 2021

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

12 - 2021

Updates

Copyright

*Correspondence: Tim Rahmel,

†These authors contributed equally to this work

This article was submitted to Alloimmunity and Transplantation, a section of the journal Frontiers in Immunology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics